This article has Open Peer Review reports available.
Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
© Cheng etal., BioMed Central Ltd. 2011
Received: 13 December 2010
Accepted: 21 January 2012
Published: 21 January 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|13 Dec 2010||Submitted||Original manuscript|
|27 Jan 2011||Reviewed||Reviewer Report - Michael Gnant|
|17 Oct 2011||Author responded||Author comments - TF Cheng|
|Resubmission - Version 2|
|17 Oct 2011||Submitted||Manuscript version 2|
|29 Oct 2011||Reviewed||Reviewer Report - Michael Gnant|
|29 Nov 2011||Author responded||Author comments - TF Cheng|
|Resubmission - Version 3|
|29 Nov 2011||Submitted||Manuscript version 3|
|21 Jan 2012||Editorially accepted|
|21 Jan 2012||Article published||10.1186/1471-2407-12-33|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.